Share the Tech - Save Lives

Share the Tech

SAVE LIVES

Currently, African countries are almost entirely dependent on imports and donations of COVID-19 and other vaccines, contributing to staggering vaccine inequity.  

If BioNTech, Pfizer and Moderna share their mRNA vaccine technology and know-how, via the World Health Organization (WHO) COVID-19 mRNA Vaccine Technology Transfer Hub based in South Africa, millions of new COVID-19 vaccines could be delivered within months.

Sharing mRNA technology with more manufacturers could be a gamechanger

The African continent is one of the regions most affected by vaccine shortages.
We need to urgently address this inequity.

SHARE ON FACEBOOK

Ask pharma to #ShareTheTech!

Sharing mRNA technology with more manufacturers could be a gamechanger

The African continent is one of the regions most affected by vaccine shortages.
We need to urgently address this inequity.

SHARE ON FACEBOOK

Ask pharma to #ShareTheTech!

The COVID-19 pandemic race to develop new vaccines has brought with it the introduction of revolutionary new technology: mRNA-based vaccines. Where available, mRNA-based COVID-19 vaccines are one of the tools saving millions of lives and slowing transmission of the virus – but too many people are being left behind waiting for access. 

It's not just that there aren't enough vaccines being produced - it's that control over who can produce and access vaccines is left to only a handful of pharmaceutical corporations, even though governments contributed billions in public money to the research and development (R&D) of these vaccines.  

So far, no company with an approved mRNA vaccine has stepped forward to contribute their technology and know-how. We urgently need BioNTech, Pfizer and Moderna – developers of the two WHO-listed mRNA vaccines for COVID-19 – to share mRNA technologies and support independent vaccine production and supply on the African continent.   

Establishing mRNA vaccine production through the WHO COVID-19 mRNA Vaccine Technology Transfer Hub, based in South Africa, at an existing manufacturing site in at least one African country, could create an annual production capacity of up to 100 million COVID-19 vaccine doses within 10 months. 

Read our full analysis in our briefing document

Join us and urge BioNTech, Pfizer and Moderna to urgently transfer the mRNA vaccine technology with prospective manufacturers. #ShareTheTech! 

Global vaccine inequity
Share the technology, save lives

Social Media graphics

Q&A